Avoro Capital Advisors’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,222,222
| Closed | -$25M | – | 49 |
|
|
2023
Q3 | $25M | Buy |
2,222,222
+582,222
| +36% | +$6.56M | 0.39% | 30 |
|
|
2023
Q2 | $5.44M | Hold |
1,640,000
| – | – | 0.07% | 40 |
|
|
2023
Q1 | $6.48M | Hold |
1,640,000
| – | – | 0.1% | 37 |
|
|
2022
Q4 | $11.9M | Buy |
1,640,000
+90,000
| +6% | +$653K | 0.18% | 34 |
|
|
2022
Q3 | $5.61M | Hold |
1,550,000
| – | – | 0.1% | 37 |
|
|
2022
Q2 | $7.02M | Hold |
1,550,000
| – | – | 0.14% | 36 |
|
|
2022
Q1 | $11.7M | Hold |
1,550,000
| – | – | 0.21% | 37 |
|
|
2021
Q4 | $17M | Hold |
1,550,000
| – | – | 0.29% | 34 |
|
|
2021
Q3 | $20M | Buy |
1,550,000
+750,000
| +94% | +$9.7M | 0.31% | 39 |
|
|
2021
Q2 | $9.1M | Hold |
800,000
| – | – | 0.16% | 42 |
|
|
2021
Q1 | $8.9M | Hold |
800,000
| – | – | 0.15% | 44 |
|
|
2020
Q4 | $9.15M | Hold |
800,000
| – | – | 0.16% | 41 |
|
|
2020
Q3 | $8.67M | Buy |
+800,000
| New | +$8.67M | 0.12% | 44 |
|